// App-Quantinova.ai

SO-8 : Soluble programmed cell death ligand 1 associated with clinical outcome in gastric cancer patients treated with nivolumab: Blood based biomarker analysis of DELIVER trial (JACCRO-GC08AR)

Researchers

Presenter

  • H. Kawakami

Principal Investigators

  • E. Inoue

  • R. Matoba

  • K. Noda

  • T. Sato

  • C. Suminaka

  • Y. Sakamoto

  • R. Kawabata

  • A. Ishiguro

  • Y. Akamaru

  • Y. Kito

  • H. Yabusaki

  • J. Matsuyama

  • M. Takahashi

  • A. Makiyama

  • H. Hayashi

  • K. Chamoto

  • T. Honjo

  • K. Nakagawa

  • W. Ichikawa

  • M. Fujii

Medical Centers

  • Kindai University Faculty of Medicine, Osakasayama, Japan

  • Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka, Japan

  • Department of Immunology and Genomic Medicine, Center for Cancer Immunotherapy and Immunobiology, Kyoto University Graduate School of Medicine, Kyoto city, Japan

  • Department of Gastroenterological Surgery, Higashiosaka City Medical Center, Higashiosaka, Japan

  • Department of Medical Oncology, Ishikawa Prefectural Central Hospital, Kanazawa, Japan

  • Division of Medical Oncology, Showa University Fujigaoka Hospital, Yokohama, Japan

  • Japan Clinical Cancer Research Organization, Tokyo, Japan

  • Cancer Center, Gifu University Hospital, Gifu, Japan

  • Showa University Research Administration Center, Showa University, Tokyo, Japan

  • Department of Medical Oncology, Teine Keijinkai Hospital, Sapporo, Japan

  • Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Japan

  • Niigata Cancer Center Hospital, Niigata, Japan

  • Division of Gastroenterological Surgery, Yokohama Municipal Citizen's Hospital, Yokohama, Japan

  • Department of Gastrointestinal Surgery, Ikeda City Hospital, Ikeda, Japan

  • Department of Surgery, Osaka Rosai Hospital, Osaka, Japan

  • Department of Medical Oncology, Osaki Citizen Hospital, Osaki, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Gastric Cancer

Biomarkers

  • C reactive protein

  • Glasgow prognostic score

  • Human albumin

  • Soluble programmed death-ligand 1

  • Soluble PD-1

Drug/Treatment

  • Nivolumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved